414 related articles for article (PubMed ID: 26791804)
1. Oncogenic circuit constituted by Ser31-HBx and Akt increases risks of chronic hepatitis and hepatocellular carcinoma.
Lee WP; Lan KH; Li CP; Chao Y; Lin HC; Lee SD
Biochim Biophys Acta; 2016 Apr; 1862(4):837-849. PubMed ID: 26791804
[TBL] [Abstract][Full Text] [Related]
2. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.
Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z
Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496
[TBL] [Abstract][Full Text] [Related]
4. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
[TBL] [Abstract][Full Text] [Related]
5. Pro-apoptotic or anti-apoptotic property of X protein of hepatitis B virus is determined by phosphorylation at Ser31 by Akt.
Lee WP; Lan KH; Li CP; Chao Y; Lin HC; Lee SD
Arch Biochem Biophys; 2012 Dec; 528(2):156-62. PubMed ID: 22982405
[TBL] [Abstract][Full Text] [Related]
6. 14-3-3ζ binds to hepatitis B virus protein X and maintains its protein stability in hepatocellular carcinoma cells.
Tang Y; Zhang Y; Wang C; Sun Z; Li L; Dong J; Zhou W
Cancer Med; 2018 Nov; 7(11):5543-5553. PubMed ID: 30358169
[TBL] [Abstract][Full Text] [Related]
7. Expression of hepatitis B virus X protein is closely correlated with the high periportal inflammatory activity of liver diseases.
Jin YM; Yun C; Park C; Wang HJ; Cho H
J Viral Hepat; 2001 Sep; 8(5):322-30. PubMed ID: 11555189
[TBL] [Abstract][Full Text] [Related]
8. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma.
Wu YH; Ai X; Liu FY; Liang HF; Zhang BX; Chen XP
Mol Med Rep; 2016 Feb; 13(2):1345-52. PubMed ID: 26648552
[TBL] [Abstract][Full Text] [Related]
9. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.
Shi Y; Wang J; Wang Y; Wang A; Guo H; Wei F; Mehta SR; Espitia S; Smith DM; Liu L; Zhang Y; Chen D
Cancer Lett; 2016 Feb; 371(2):285-91. PubMed ID: 26706415
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction.
Zheng Y; Ming P; Zhu C; Si Y; Xu S; Chen A; Wang J; Zhang B
J Biol Chem; 2019 Mar; 294(13):4815-4827. PubMed ID: 30659097
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
[TBL] [Abstract][Full Text] [Related]
12. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
[TBL] [Abstract][Full Text] [Related]
13. HBX Protein-Induced Downregulation of microRNA-18a is Responsible for Upregulation of Connective Tissue Growth Factor in HBV Infection-Associated Hepatocarcinoma.
Liu X; Zhang Y; Wang P; Wang H; Su H; Zhou X; Zhang L
Med Sci Monit; 2016 Jul; 22():2492-500. PubMed ID: 27421245
[TBL] [Abstract][Full Text] [Related]
14. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis.
Zhu R; Mok MT; Kang W; Lau SS; Yip WK; Chen Y; Lai PB; Wong VW; To KF; Sung JJ; Cheng AS; Chan HL
J Pathol; 2015 Sep; 237(1):38-49. PubMed ID: 25925944
[TBL] [Abstract][Full Text] [Related]
15. Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling.
He B; Peng F; Li W; Jiang Y
J Cell Biochem; 2019 Mar; 120(3):2908-2918. PubMed ID: 30500989
[TBL] [Abstract][Full Text] [Related]
16. Sorafenib overcomes the chemoresistance in HBx-expressing hepatocellular carcinoma cells through down-regulation of HBx protein stability and suppresses HBV gene expression.
Kim HY; Jung HU; Yoo SH; Yoo KS; Cheong J; Park BS; Yun I; Yoo YH
Cancer Lett; 2014 Dec; 355(1):61-9. PubMed ID: 25218348
[TBL] [Abstract][Full Text] [Related]
17. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
[TBL] [Abstract][Full Text] [Related]
18. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
19. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
20. HBx-K130M/V131I Promotes Liver Cancer in Transgenic Mice via AKT/FOXO1 Signaling Pathway and Arachidonic Acid Metabolism.
Chiu AP; Tschida BR; Sham TT; Lo LH; Moriarity BS; Li XX; Lo RC; Hinton DE; Rowlands DK; Chan CO; Mok DKW; Largaespada DA; Warner N; Keng VW
Mol Cancer Res; 2019 Jul; 17(7):1582-1593. PubMed ID: 30975706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
